Global Biologics Contract Development Market Size & Outlook
Global biologics contract development market, 2018-2030 (US$M)
Related Markets
Global biologics contract development market highlights
- The global biologics contract development market generated a revenue of USD 8,003.1 million in 2023 and is expected to reach USD 13,827.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.1% by 2030.
- In terms of segment, mammalian source accounted for a revenue of USD 4,386.1 million in 2023.
- Mammalian Source is the most lucrative source segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 8,003.1 million |
| Market revenue in 2030 | USD 13,827.0 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Mammalian source |
| Fastest growing segment | Mammalian Source |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microbial Source, Mammalian Source, Other Source |
Other key industry trends
- In terms of revenue, the North America accounted for 41.9% of the global biologics contract development market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, South Africa is the fastest growing regional market and is projected to reach USD 32.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Contract Development Market Scope
Biologics Contract Development Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biologics contract development market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract development market will help companies and investors design strategic landscapes.
Mammalian source was the largest segment with a revenue share of 54.81% in 2023. Horizon Databook has segmented the Global biologics contract development market based on microbial source, mammalian source, other source covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biologics Contract Development Source Outlook (Revenue, USD Million, 2018-2030)
- Microbial Source
- Mammalian Source
- Other Source
- Global Biologics Contract Development Service Outlook (Revenue, USD Million, 2018-2030)
- Cell Line Development (CLD)
- Microbial (CLD)
- Mammalian(CLD)
- Others (CLD)
- Process Development (PD)
- Upstream
- Microbial (Upstream)
- Mammalian (Upstream)
- Others (Upstream)
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Other Downstream
- Upstream
- Other Service
- Cell Line Development (CLD)
- Global Biologics Contract Development Indication Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Other Indications
Reasons to subscribe to Global biologics contract development market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biologics contract development market databook
-
Our clientele includes a mix of biologics contract development market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics contract development market, including forecasts for subscribers. This global databook contains high-level insights into Global biologics contract development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biologics contract development market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biologics contract development market size, 2023 (US$M)
Global biologics contract development market share, by source, 2023 & 2030 (%, US$M)
Biologics contract development market: Opportunity assessment by country
Global biologics contract development market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
